Skip to content

Surgical Management of Optic Disc Pit Maculaopathy

Pars Plana Vitrectomy With Internal Limiting Membrane Peeling in Optic Disc Pit Maculopathy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03185936
Enrollment
9
Registered
2017-06-14
Start date
2011-03-01
Completion date
2017-04-01
Last updated
2017-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maculopathy, Optic Disc Structural Anomaly

Keywords

optic disc pit, retinal detachment, maculopathy

Brief summary

To evaluate the anatomical and functional results of pars plana vitrectomy (PPV) combined with internal limiting membrane (ILM) peeling, endolaser photocoagulation and gas tamponade in management of optic disc pit (ODP) maculopathy.

Detailed description

As it is well known, optic disc pit (ODP) is a rare congenital disease which is usually associated with maculopathy (ODP-M) in the form of intraretinal and subretinal fluid accumulation at the macular area leading to visual impairment. With no definite treatment and absence of guidelines for its management, the invistigators considered their prospective, interventional case series to evaluate the anatomical and functional results of pars plana vitrectomy (PPV) combined with internal limiting membrane (ILM) peeling, endolaser photocoagulation and gas tamponade in management of optic disc pit (ODP) maculopathy.

Interventions

PROCEDUREpars plana vitrectomy with internal limiting membrane (ILM) peeling

pars plana vitrectomy (PPV) combined with internal limiting membrane (ILM) peeling, endolaser photocoagulation and gas tamponade in management of optic disc pit (ODP) maculopathy.

Sponsors

Minia University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
15 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients included in this study are those with ODP associated with macular detachment

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frameDescription
anatomical improvement6 monthsRetinal reattachment

Secondary

MeasureTime frameDescription
Functional improvement6 monthsVisual acuity letters gain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026